Pamidronic Acid

Back to search

Molecule Structure

Scientific Name

Pamidronic Acid

Description of the Drug

Pamidronic acid is a bisphosphonate used to treat Paget’s disease, to treat hypercalcemia of malignancy, and to treat osteolytic bone lesions.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00282

Brand Name(s)

Not Available

Company Owner(s)

Mn Pharmaceuticals, Fresenius Kabi Usa Llc, Sun Pharma Global Inc, Mylan Laboratories Ltd, Sagent Pharmaceuticals Inc, Hospira Inc, American Regent Inc, Aesgen Inc, Teva Pharmaceuticals Usa, Dr Reddys Laboratories Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Farnesyl diphosphate synthase SINGLE PROTEIN INHIBITOR CHEMBL1782

Unichem Links

SureChEMBL SCHEMBL18361
PharmGKB PA450767
Human Metabolome Database HMDB0014427
DrugBank DB00282
PubChem: Thomson Pharma 14798245
PubChem 44400012 4674
Mcule MCULE-4373491291
Nikkaji J221.669H
PDBe 210
BindingDB 12581
EPA CompTox Dashboard DTXSID4023414
DrugCentral 2048
Brenda 212813 7519
ChemicalBook CB8107554
Guide to Pharmacology 7259
rxnorm PAMIDRONATE DISODIUM PAMIDRONATE PAMIDRONIC ACID
KEGG Ligand C07395
ChEBI 7903
ZINC ZINC000003812862